Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
Taiwan · Delayed Price · Currency is TWD 32.15
+0.05 (0.16%)
Apr 17, 2026, 1:30 PM CST
Sinphar Pharmaceutical Market Cap
Sinphar Pharmaceutical has a market cap or net worth of 6.11 billion as of April 17, 2026. Its market cap has increased by 5.16% in one year.
Market Cap
6.11B
Enterprise Value
6.90B
Revenue
3.37B
Ranking
n/a
PE Ratio
16.74
Stock Price
32.15
Market Cap Chart
Since April 23, 2003, Sinphar Pharmaceutical's market cap has increased from 1.13B to 6.11B, an increase of 443.35%. That is a compound annual growth rate of 7.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 6.11B | 5.41% |
| Dec 31, 2025 | 5.80B | 2.64% |
| Dec 31, 2024 | 5.65B | -0.75% |
| Dec 29, 2023 | 5.69B | 2.41% |
| Dec 30, 2022 | 5.56B | 14.71% |
| Dec 30, 2021 | 4.85B | -6.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adimmune | 7.80B |
| TaiGen Biopharmaceuticals Holdings | 7.51B |
| Acepodia | 7.25B |
| Savior Lifetec | 6.18B |
| Mycenax Biotech | 6.18B |
| AnnJi Pharmaceutical | 5.75B |
| Steminent Biotherapeutics | 5.69B |
| Panion & Bf Biotech | 5.53B |